| Serial Number | 88476971 |
| Word Mark | T-LITE |
| Filing Date | Monday, June 17, 2019 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Sunday, April 11, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Medical and pharmaceutical research services; pharmaceutical research and development; pharmaceutical research and development related to the prevention or treatment of disease with substances that stimulate the immune response; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; scientific and technological services, namely, research and design services in the field of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological services consultation services in the field of development, manufacturing and testing of pharmaceuticals and biopharmaceuticals; providing product research and development in the pharmaceutical field for purposes of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological consultation services in the field of pharmaceutical research and pharmacology; custom development of pharmaceutical, biopharmaceutical and chemical products; providing evaluation testing for pharmaceutical, biopharmaceutical and chemical products, and medical devices featuring testing for safety, toxicity, content, identity, purity, configuration and function, using chemical, in vitro or in vivo assays, analyses and models; pre-clinical and non-clinical evaluation testing of pharmaceutical, biopharmaceutical and chemical products performed primarily using animals and other biological models; pharmaceutical, biopharmaceutical, and chemical research and development for others; pharmaceutical research in the field of immunotherapy; pharmaceutical research for the treatment of infectious, deficiency, hereditary, and physiological diseases |
| Pseudo Mark | T LIGHT |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 27, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Soteria Biotherapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94107 |
| Event Date | Event Description |
| Monday, April 12, 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Sunday, April 11, 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, September 28, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 28, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, September 28, 2020 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 10, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, March 10, 2020 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, March 10, 2020 | SUSPENSION LETTER WRITTEN |
| Saturday, March 7, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, March 6, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 6, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, September 9, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 9, 2019 | NON-FINAL ACTION E-MAILED |
| Monday, September 9, 2019 | NON-FINAL ACTION WRITTEN |
| Sunday, September 8, 2019 | ASSIGNED TO EXAMINER |
| Thursday, June 27, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, June 20, 2019 | NEW APPLICATION ENTERED IN TRAM |